Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Rang în acțiuni #2037
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preț acțiune
$173.78
Capitalizare de piață
$10.25B
Schimbare (1 zi)
4.19%
Schimbare (1 an)
118.67%
Țară
US
Tranzacționează Glaukos Corporation (GKOS)

Categorie

Healthcare
Istoricul spliturilor pentru Glaukos Corporation (GKOS)
Acțiunea Glaukos Corporation (simbol: GKOS) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 20, 2026.
O acțiune GKOS cumpărată înainte de Oct 20, 2026 este echivalentă astăzi cu 0 acțiuni GKOS.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE